Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
IT IS ONE OF THE IRONIES OF HEALTHCARE that it has taken the prestigious Institute of Medicine (IOM) more than three decades to fully recognize the necessary and essential role that continuous improvement and the associated disciplines of Lean, Six Sigma, and process improvement must play if the American healthcare system is to meet the …
IOM Endorses Continuous Improvement, Lean Read More »
CEO SUMMARY: One new byword coming to healthcare in the United States is the “continuously-learning healthcare system.” At the upcoming Lab Quality Confab in San Antonio next month, lab managers and pathologists can learn more about how to achieve and sustain continuous improvement in their laboratory organization. Pathologists and lab managers who have been active …
Process Improvement Coming to Healthcare Read More »
CEO SUMMARY: Danaher Corporation continues to fuel growth by continually acquiring in vitro diagnostics (IVD) companies. Its latest purchase is Iris International, which manufactures automated urine microscopy systems. Danaher also has $5 billion available that it could spend in the next two years on acquisitions. Because of its acquisitions over the past decade, Danaher now …
More IVD Consolidation as Danaher Acquires Iris Read More »
CEO SUMMARY: There’s a treasure trove of information and insights about how physicians use clinical laboratory tests contained in survey data recently collected by a team from the Centers for Disease Control and Prevention. Designed to identify challenges in how physicians utilize laboratory tests, the survey findings offer a road map about how innovative clinical …
CDC Surveys Docs’ Use of Laboratory Test Results Read More »
CEO SUMMARY: There will be an expanding role for innovative clinical labs as healthcare moves forward on its path toward personalized medicine. However, to capitalize on this opportunity, pathology groups and clinical labs will need to beef up their information systems. They will also need to recruit lab staff who are skilled in interpreting molecular …
Unprecedented Growth Rates for Molecular Testing Read More »
URINE DRUG TESTING for pain management may be a challenging business for clinical labs given that compliance officers in the states and in the federal government have successfully pursued lab compliance abuses in this line of business in recent years. Now comes news that private equity firm Ampersand Capital Partners of Wellesley, Massachusetts, is to …
Ampersand Buys Calloway Labs, Enters Pain Management Market Read More »
Definiens AG, one of the major players in the fast-growing market for digital pathology, raised $12.8 million in additional capital funding. The company, based in Munich, Germany, manufacturers systems for digital image analysis. Definiens stated that the new funds will be used for “commercial expansion of its current business and to develop and commercialize innovative …
October 8, 2012 “Intelligence: Late Breaking Lab News” Read More »
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.